MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer's and vascular dementia and their epistatic interaction

Neurobiology of Aging

Volumn 33, Issue 5, 2012, Pages 1003.e1-1003.e8

  Mansoori, Nasim ^a   Tripathi, Manjari ^a   Luthra, Kalpana ^a   Alam, Rizwan ^a,b   Lakshmy, Ramakrishnan ^a   Sharma, Subhadra ^a   Arulselvi, Subramanyam ^a   Parveen, Shama ^b   Mukhopadhyay, Asok K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Epistasis; Homocysteine; Indian population; Interleukin 6; MTHFR; Polymorphism; Vascular dementia

Indexed keywords

HOMOCYSTEINE;

AGED; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; INTERLEUKIN 6 GENE; MAJOR CLINICAL STUDY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MOLECULAR PATHOLOGY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL;

EID: 84858334344     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.09.018     Document Type: Article

References (47)

1. Anello G., Guéant-Rodríguez R.M., Bosco P., Guéant J.L., Romano A., Namour B., Spada R., Caraci F., Pourié G., Daval J.L., Ferri R. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 2004, 15:859-861.
2. Arioǧul S., Cankurtaran M., Daǧli N., Khalil M., Yavuz B. Vitamin B12, folate, homocysteine and dementia: are they really related?. Arch. Gerontol. Geriatr 2005, 40:139-146.
3. Beilby J., Rossi E. Number 58: homocysteine and disease. Pathology 2000, 32:262-273.
4. Brattström L., Wilcken D.E., Ohrvik J., Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 1998, 98:2520-2526.
5. Capurso C., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso S.A., Capurso A., Panza F. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe. Exp. Gerontol 2004, 39:1567-1573.
6. Cascalheira J.F., João S.S., Pinhanços S.S., Castro R., Palmeira M., Almeida S., Faria M.C., Domingues F.C. Serum homocysteine: interplay with other circulating and genetic factors in association to Alzheimer's type dementia. Clin. Biochem 2009, 42:783-790.
7. Castro R., Rivera I., Blom H.J., Jakobs C., Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J. Inherit. Metab. Dis 2006, 29:3-20.
8. Combarros O., Cortina-Borja M., Smith A.D., Lehmann D.J. Epistasis in sporadic Alzheimer's disease. Neurobiol. Aging 2009, 30:1333-1349.
9. Da Silva V.C., Ramos F.J., Freitas E.M., de Brito-Marques P.R., Cavalcanti M.N., D'Almeida V., Cabral-Filho J.E., Muniz M.T. Alzheimer's disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms. Arq. Neuro Psiquiatr 2006, 64:941-945.
10. Del Bo R., Angeretti N., Lucca E., De Simoni M.G., Forloni G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci. Lett 1995, 188:70-74.
11. Deloughery T.G., Evans A., Sadeghi A., McWilliams J., Henner W.D., Taylor L.M., Press R.D. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 1996, 94:3074-3078.
12. Devlin A.M., Clarke R., Birks J., Evans J.G., Halsted C.H. Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. Am. J. Clin. Nutr 2006, 83:708-713.
13. Dufouil C., Alpérovitch A., Ducros V., Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann. Neurol 2003, 53:214-221.
14. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., Rozen R. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet 1995, 10:111-113.
15. Hankey G.J., Eikelboom J.W. Homocysteine and vascular disease. Lancet 1999, 354:407-413.
16. Hanson N.Q., Aras O., Yang F., Tsai M.Y. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin. Chem 2001, 47:661-666.
17. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996, 93:7-9.
18. Ji C., Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J. Gastroenterol 2004, 10:1699-1708.
19. Kalmijn S., Launer L.J., Lindemans J., Bots M.L., Hofman A., Breteler M.M. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am. J. Epidemiol 1999, 150:283-289.
20. Kruman I.I., Kumaravel T.S., Lohani A., Pedersen W.A., Cutler R.G., Kruman Y., Haughey N., Lee J., Evans M., Mattson M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci 2002, 22:1752-1762.
21. Kumar J., Das S.K., Sharma P., Karthikeyan G., Ramakrishnan L., Sengupta S. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J. Hum. Genet 2005, 50:655-663.
22. Liu H., Yang M., Li G.M., Qiu Y., Zheng J., Du X., Wang J.L., Liu R.W. The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: a meta-analysis. J. Neurol. Sci 2010, 294:74-80.
23. Luchsinger J.A., Tang M.X., Shea S., Miller J., Green R., Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004, 62:1972-1976.
24. Luthra K., Tripathi M., Grover R., Dwivedi M., Kumar A., Dey A.B. Apolipoprotein E gene polymorphism in Indian patients with Alzheimer's disease and vascular dementia. Dement. Geriatr. Cogn. Disord 2004, 17:132-135.
25. Mansoori N., Tripathi M., Alam R., Luthra K., Ramakrishnan L., Parveen S., Mukhopadhyay A.K. IL-6-174 G/C and ApoE gene polymorphisms in Alzheimer's and vascular dementia patients attending the cognitive disorder clinic of the All India Institute of Medical Sciences, New Delhi. Dement. Geriatr. Cogn. Disord 2010, 30:461-468.
26. Markan S., Sachdeva M., Sehrawat B.S., Kumari S., Jain S., Khullar M. MTHFR 677 CT/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians. Mol. Cell. Biochem 2007, 302:125-131.
27. Miller S.A., Dykes D.D., Polesky H.S. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1998, 16:1215.
28. Nishiyama M., Kato Y., Hashimoto M., Yukawa S., Omori K. Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementi-an epidemiological study using the polymerase chain reaction (PCR) method. J. Epidemiol 2000, 10:163-172.
29. Pandey P., Pradhan S., Modi D.R., Mittal B. MTHFR and ACE gene polymorphisms and risk of vascular and degenerative dementias in the elderly. Brain Cogn 2009, 71:295-299.
30. Postiglione A., Milan G., Ruocco A., Gallotta G., Guiotto G., Di Minno G. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. Gerontology 2001, 47:324-329.
31. Quadri P., Fragiacomo C., Pezzati R., Zanda E., Forloni G., Tettamanti M., Lucca U. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am. J. Clin. Nutr 2004, 80:114-122.
32. Religa D., Styczynska M., Peplonska B., Gabryelewicz T., Pfeffer A., Chodakowska M., Luczywek E., Wasiak B., Stepien K., Golebiowski M., Winblad B., Barcikowska M. Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement. Geriatr. Cogn. Disord 2003, 16:64-70.
33. Ringheim G.E., Szczepanik A.M., Petko W., Burgher K.L., Zhu S.Z., Chao C.C. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. Brain Res Mol Brain Res 1998, 55:35-44.
34. Sai X., Kawamura Y., Kokame K., Yamaguchi H., Shiraishi H., Suzuki R., Suzuki T., Kawaichi M., Miyata T., Kitamura T., De Strooper B., Yanagisawa K., Komano H. Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein. J. Biol. Chem 2002, 277:12915-12920.
35. Seripa D., Forno G.D., Matera M.G., Gravina C., Margaglione M., Palermo M.T., Wekstein D.R., Antuono P., Davis D.G., Daniele A., Masullo C., Bizzarro A., Gennarelli M., Fazio V.M. Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurobiol. Aging 2003, 24:933-939.
36. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med 2002, 346:476-483.
37. Sharma P., Senthilkumar R.D., Brahmachari V., Sundaramoorthy E., Mahajan A., Sharma A., Sengupta S. Mining literature for a comprehensive pathway analysis: A case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 2006, 5:1.
38. Su S.J., Huang L.W., Pai L.S., Liu H.W., Chang K.L. Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition 2005, 21:994-1002.
39. van Oijen M., Arp P.P., de Jong F.J., Hofman A., Koudstaal P.J., Uitterlinden A.G., Breteler M.M. Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study. Neurosci. Lett 2006, 402:113-117.
40. Wang B., Jin F., Kan R., Ji S., Zhang C., Lu Z., Zheng C., Yang Z., Wang L. Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer's disease. J. Mol. Neurosci 2005, 27:23-27.
41. Wehr H., Bednarska-Makaruk M., Łojkowska W., Graban A., Hoffman-Zacharska D., Kuczyńska-Zardzewiały A., Mrugała J., Rodo M., Bochyńska A., Sułek A., Ryglewicz D. Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia. Dement. Geriatr. Cogn. Disord 2006, 22:1-7.
42. Weisberg I., Tran P., Christensen B., Sibani S., Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab 1998, 64:169-172.
43. Wolozin B., Lesch P., Lebovics R., Sunderland T. A.E. Bennett Research Award 1993. Olfactory neuroblasts from Alzheimer donors: studies on APP processing and cell regulationBiol. Psychiatry 1993, 34:824-838.
44. Yoo J.H., Choi G.D., Kang S.S. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler. Thromb. Vasc. Biol 2000, 20:1921-1925.
45. Zhang M.Y., Miao L., Li Y.S., Hu G.Y. Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to Alzheimer's disease. Neurosci. Res 2010, 68:142-150.
46. Zhang Y.D., Ke X.Y., Shen W., Liu Y. Relationship of homocysteine and gene polymorphisms of its related metabolic enzymes with Alzheimer's disease. Chin. Med. Sci. J 2005, 20:247-251.
47. Zuliani G., Ble A., Zanca R., Munari M.R., Zurlo A., Vavalle C., Atti A.R., Fellin R. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol. Scand 2001, 103:304-308.